IL319379A - Novel cholecystokinin 2 receptor-binding molecules derived from minigastrin for imaging and targeted radiotherapy - Google Patents

Novel cholecystokinin 2 receptor-binding molecules derived from minigastrin for imaging and targeted radiotherapy

Info

Publication number
IL319379A
IL319379A IL319379A IL31937925A IL319379A IL 319379 A IL319379 A IL 319379A IL 319379 A IL319379 A IL 319379A IL 31937925 A IL31937925 A IL 31937925A IL 319379 A IL319379 A IL 319379A
Authority
IL
Israel
Prior art keywords
minigastrin
imaging
novel
receptor binding
binding molecules
Prior art date
Application number
IL319379A
Other languages
English (en)
Hebrew (he)
Original Assignee
Technische Universit?T M?Nchen
Universit?T Augsburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technische Universit?T M?Nchen, Universit?T Augsburg filed Critical Technische Universit?T M?Nchen
Publication of IL319379A publication Critical patent/IL319379A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A61K51/065—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules conjugates with carriers being macromolecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
IL319379A 2022-09-20 2023-05-19 Novel cholecystokinin 2 receptor-binding molecules derived from minigastrin for imaging and targeted radiotherapy IL319379A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP22196630 2022-09-20
PCT/EP2023/063469 WO2024061483A1 (en) 2022-09-20 2023-05-19 Novel minigastrin-derived cholecystokinin 2 receptor binding molecules for imaging and targeted radiotherapy

Publications (1)

Publication Number Publication Date
IL319379A true IL319379A (en) 2025-05-01

Family

ID=83994946

Family Applications (1)

Application Number Title Priority Date Filing Date
IL319379A IL319379A (en) 2022-09-20 2023-05-19 Novel cholecystokinin 2 receptor-binding molecules derived from minigastrin for imaging and targeted radiotherapy

Country Status (9)

Country Link
EP (2) EP4590347A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025532619A (cg-RX-API-DMAC7.html)
KR (1) KR20250073200A (cg-RX-API-DMAC7.html)
CN (1) CN119907695A (cg-RX-API-DMAC7.html)
AU (1) AU2023345654A1 (cg-RX-API-DMAC7.html)
CA (1) CA3264385A1 (cg-RX-API-DMAC7.html)
IL (1) IL319379A (cg-RX-API-DMAC7.html)
MX (1) MX2025003151A (cg-RX-API-DMAC7.html)
WO (1) WO2024061483A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12642876B1 (en) 2025-10-30 2026-06-02 Perspective Therapeutics, Inc. Cholecystokinin-2 receptor targeted compounds and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3412303A1 (en) * 2017-06-08 2018-12-12 Medizinische Universität Innsbruck Improved pharmacokinetics and cholecystokinin-2 receptor (cck2r) targeting for diagnosis and therapy
KR20240027896A (ko) * 2017-07-28 2024-03-04 테크니쉐 우니베르지테트 뮌헨 이중 모드 방사성 트레이서 및 치료법
EP4023250A1 (en) * 2021-01-04 2022-07-06 Technische Universität München Dual mode radiotracer and -therapeutics

Also Published As

Publication number Publication date
KR20250073200A (ko) 2025-05-27
CA3264385A1 (en) 2024-03-28
CN119907695A (zh) 2025-04-29
JP2025532619A (ja) 2025-10-01
AU2023345654A1 (en) 2025-02-27
WO2024061483A1 (en) 2024-03-28
MX2025003151A (es) 2025-04-02
EP4590347A1 (en) 2025-07-30
EP4631959A3 (en) 2025-12-17
EP4631959A2 (en) 2025-10-15

Similar Documents

Publication Publication Date Title
Demizu et al. Design and synthesis of estrogen receptor degradation inducer based on a protein knockdown strategy
MX2010001378A (es) Uso terapeutico de anticuerpos del receptor anti-tweak.
IL280535A (en) Muscle-directed couplings and their uses in the treatment of Friedreich's ataxia
CA3264385A1 (en) NEW MINIGASTRINE-DERIVED CHOLECYSTOKIN 2 RECEPTOR-BINDING MOLECULES FOR TARGETED IMAGING AND RADIOTHERAPY
SA523442921B1 (ar) جزيئات ربط علاجية
MX2009012749A (es) Compuestos heterociclicos como moduladores positivos del receptor de glutamato metabotropico 2 (receptor mglu2).
CY1118566T1 (el) Διαγνωση με χρηση ιντερφερονης τυπου 1
IL316848A (en) Antigen-binding molecules targeting SARS-CoV-2
IL128003A (en) MULTISPECIFIC BINDING MOLECULES COMPRISING A BINDING DETERMINANT WHICH BINDS AN FCalpha RECEPTOR
MX2007006102A (es) Agentes anti-cancer de union a tubulina y profarmacos de los mismos.
IL320410A (en) Combination therapy involving bispecific antibodies containing an NRP1 binding domain
MX2020007167A (es) Composiciones y metodos para tratar enfermedades metabolicas.
HK40122619A (en) Novel minigastrin-derived cholecystokinin 2 receptor binding molecules for imaging and targeted radiotherapy
MX2020000673A (es) Composiciones que contienen conjugados análogos de cannabinoides y métodos de uso.
IL290280A (en) Estrogen receptor modulators for the treatment of mutants
IL299648A (en) Anti-interleukin 36 receptor therapy for psoriasis
SMT202400493T1 (it) Terapia a base di immunoconiugato di tnf-a per il trattamento di tumori cerebrali
IL316017A (en) Combined treatment for cancer
WO2023150510A3 (en) Car and polyspecific binding molecules targeting solid tumors
ZA202209478B (en) Rat fixator for cheek acupuncture
BR112023023284A2 (pt) Anticorpos para tratamento de alfa-sinucleinopatias
IL298170B1 (en) Tendon fixation plate
MX2019010732A (es) Uso de moduladores de receptor de glucocorticoide en el tratamiento de tumores secretores de catecolamina.
KR102467285B9 (ko) 우황청심환을 포함하는 파킨슨 질환 예방 또는 치료용 약학 조성물
IL317689A (en) Binding molecules for cancer treatment